Dual Perspectives on DAPT
DEFLECT III: Cerebral protection device safe at 30 days after TAVR
Lipid Forum II Highlights
Platelet Function and Genetic Testing: Current Status and Use
New data from the PRAGUE 13 trial presented at EuroPCR demonstrate no difference in favor of multivessel PCI over culprit-only primary PCI in patients with STEMI.
Ota Hlinomaz, MD, PhD, from St. Anne University Hospital in Brno, Czech Republic, and colleagues studied two management strategies in patients with STEMI who had 70% or greater stenosis in a nonculprit artery.
This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC
CVD prevention, treatment challenging as patients with HIV and HCV live longer
A tribute to Elijah Saunders, MD
A look at coagulation assays for target-specific oral anticoagulants
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.